Back to discover
Disease

Intestinal Neoplasms

Late-stage therapeutic developmentEmerging researchRising momentum
MeSHIntestinal Neoplasms
3
Publications
7
Clinical trials
2024
Latest publication
Latest activity
beta

Recent clinical, regulatory, research and industry developments relating to this disease.

What's happening now

An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.

Executive briefingUpdating summary…Momentum: Low
Key developments
  • 2 clinical trials expected to report results, the earliest in Q4 2026.
Upcoming Milestones
Clinical Milestones3View
Results expected 2
Recently completed 1
Activity timeline3

Clinical trials

6 sponsors · 1 new · 1 completed in the last 12 months (net +1)

The current development programme across all trial phases.

Clinical programme
7
All trials
2
Active
3
Late-stage
4
Completed
Late-stage studies

AN INTERVENTIONAL, PHASE 3, DOUBLE-BLIND, RANDOMIZED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF PF-08634404 IN COMBINATION WITH CHEMOTHERAPY VERSUS BEVACIZUMAB IN COMBINATION WITH CHEMOTHERAPY IN TREATMENT-NAÏVE PARTICIPANTS WITH METASTATIC COLORECTAL CANCER

Phase 3 · Recruiting · Pfizer

A Multinational, Randomized, Phase III Study of FOLFIRI With/Without Bevacizumab Versus Irinotecan With/Without Bevacizumab As Second-line Therapy in Patients With Metastatic Colorectal Cancer

Phase 3 · Recruiting · Sun Yat-sen University

A Multinational, Randomized, Phase III Study of XELIRI With/Without Bevacizumab Versus FOLFIRI With/Without Bevacizumab As Second-line Therapy in Patients With Metastatic Colorectal Cancer

Phase 3 · Completed · Epidemiological and Clinical Research Information Network
Recently completed

A Prospective, Multicenter Randomized Controlled Study of the Application of Preoperative FOLFOXIRI Chemotherapy Combined With Lateral Lymph Node Dissection in Low- and Medium-lying Rectal Cancer With Lateral Lymph Node Metastasis

N/A · Completed · Cancer Institute and Hospital, Chinese Academy of Medical Sciences

A Phase 1/2 Study of the Highly-selective RET Inhibitor, BLU-667, in Patients With Thyroid Cancer, Non-Small Cell Lung Cancer (NSCLC) and Other Advanced Solid Tumors

Phase 1/2 · Completed · Hoffmann-La Roche

An Open, Single Arm, Multicenter, Exploratory Phase II Clinical Trial of Anlotinib Hydrochloride Capsules Combined With CAPEOX in RAS and BRAF Wild-type Patients With Metastatic Colorectal Carcinoma as 1st Therapy

Phase 2 · Completed · Zhejiang University

A Multinational, Randomized, Phase III Study of XELIRI With/Without Bevacizumab Versus FOLFIRI With/Without Bevacizumab As Second-line Therapy in Patients With Metastatic Colorectal Cancer

Phase 3 · Completed · Epidemiological and Clinical Research Information Network

Research activity

3 papers

Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.

Publications over time
20102024
Major themes7
  • Capsule Endoscopy1
  • Double-Balloon Enteroscopy1
  • Intestinal Neoplasms1
  • Neoplasm Staging1
  • Neuroendocrine Tumors1
  • Pancreatic Neoplasms1
  • Stomach Neoplasms1
Leading journals3
  • CA: a cancer journal for clinicians1
  • Current gastroenterology reports1
  • Endoscopy1
Leading researchers8
  • Adler SN1
  • Albert J1
  • Anaya DA1
  • Asare EA1
  • Baltes P1
  • Barbaro F1
  • Bellizzi AM1
  • Bergsland E1
Affiliations (unnormalised)6
  • Catholic University1
  • Centre Hospitalier Lyon Sud1
  • Centro Hospitalar do Alto Ave1
  • Chaim Sheba Medical Center1
  • Clinical Psychology Unit1
  • Duke University Medical Center1

Reference

Authoritative identity, definition & identifiers.

Defined in MeSH

Tumors or cancer of the INTESTINES.

Identifiers
MeSHIntestinal Neoplasms
References & data sources
  • Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
  • Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
  • Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
  • Related entities are derived from literature co-mention (studied together) — associative, not causal.